Article info

Download PDFPDF
Research paper
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS

Authors

  • Mike P Wattjes Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany Department of Radiology and Nuclear Medicine, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Martijn T Wijburg Department of Radiology and Nuclear Medicine, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Neurology, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Jeroen van Eijk Department of Neurology, Jeroen Bosch Ziekenhuis, s’Hertogenbosch, The Netherlands PubMed articlesGoogle scholar articles
  • Stephan Frequin Department of Neurology, St Antonius Hospital, Nieuwegein, The Netherlands PubMed articlesGoogle scholar articles
  • Bernard M J Uitdehaag Department of Neurology, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Frederik Barkhof Department of Radiology and Nuclear Medicine, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Institutes of Neurology and Healthcare Engineering, UCL, London, UK PubMed articlesGoogle scholar articles
  • Clemens Warnke Department of Neurology, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany Department of Neurology, University Hospital of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Joep Killestein Department of Neurology, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • On behalf of the Dutch-Belgian Natalizumab-Associated PML Study Group
    Google scholar articles
  1. Correspondence to Dr Mike P Wattjes, Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Carl-Neuberg-Straße 1, D-30625 Hannover, Germany; wattjes.mike{at}mh-hannover.de
View Full Text

Citation

Wattjes MP, Wijburg MT, van Eijk J On behalf of the Dutch-Belgian Natalizumab-Associated PML Study Group, et al
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS

Publication history

  • Received July 16, 2017
  • Revised October 16, 2017
  • Accepted October 19, 2017
  • First published November 15, 2017.
Online issue publication 
February 19, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.